Status:
UNKNOWN
Evaluation of Vaginal Dose in Cervical Cancer Patients Treated With Radiotherapy
Lead Sponsor:
Xi'an Jiaotong University
Conditions:
Cervical Cancer
Eligibility:
FEMALE
Up to 60 years
Brief Summary
Cervical cancer is the most common malignant in women with the average five-year overall survival rate as high as 70%. Radiation therapy is the main treatment for cervical cancer. Vagina is one of the...
Detailed Description
1. a detailed record of the irradiation dose and R-V point dose for all patients PIBS / PIBS ± 2cm, VRL data were taken. 2. according to CTCAE v3.0 standard, accurate and detailed record of patient tr...
Eligibility Criteria
Inclusion
- Pathologically confirmed cervical cancer patients;
- FIGO stage ⅠA- ⅣA patients who underwent radical radiotherapy;
- Any pathological type
Exclusion
- FIGO staging of cervical cancer ⅢA;
- Age \> 60 years
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2019
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03257475
Start Date
March 1 2017
End Date
August 30 2019
Last Update
August 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi'an, Shaanxi, China, 710061